Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma
PHASE2
This is a prospective, open-labelled study to evaluate the efficacy and saf...
Clinical Study of Camrelizumab, Apatinib Mesylate and Nab-paclitaxel Combined With Oxplatin and S-1 in the Neoadjuvant Treatment of Locally Advanced Gastric Cancer With Different Genotypes
PHASE2
To evaluate the clinical efficacy of camrelizumab, apatinib Mesylate and na...
A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.
PHASE3
This randomized, open-label phase 3 study will evaluate the safety and effi...
Status
Terminated
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University